BSPCE (French Startup Share Warrants) 2026: Benefits, Drawbacks, and How They Work

Up to date as of May 15, 2026.

BSPCE (Bons de Souscription de Parts de Créateur d'Entreprise) are the dominant equity compensation instrument in the French startup ecosystem. Their appeal is straightforward: zero social charges for the company, a capped 30% flat tax for the beneficiary, and a long-term alignment of interests between founders, employees, and investors.

In brief: a BSPCE is a warrant giving its holder the right to purchase shares in the company at a pre-set exercise price, after a vesting period defined in the allocation plan. The taxable gain at the time of sale equals the sale price minus the exercise price, and is taxed at a flat 30% rate (PFU: 12.8% income tax + 17.2% social levies) provided the company is more than 3 years old at the time of sale.

The BSPCE regime is codified in Article 163 bis G of the French General Tax Code (CGI), introduced by the Finance Act of 1997. Subsequent reforms progressively broadened its scope. The 2022 Finance Act (LFI 2022) raised the maximum company age at time of issuance from 7 to 15 years, extending eligibility to a wider range of growth-stage companies.

The taxation of the sale gain is governed by CGI Article 200 A. The social security treatment is covered by the Code de la Securite Sociale and clarified in the BOFiP administrative guidelines (BOI-RSA-ES-20-20).

To issue BSPCE, a company must simultaneously satisfy all of the following conditions:

Legal form: only SA (joint-stock company), SAS (simplified joint-stock company), or SCA (limited partnership with shares). A SARL (limited liability company) cannot issue BSPCE.

Activity: the company must carry on a commercial, industrial, craft, professional, agricultural, or financial activity. Real estate asset management activities are expressly excluded.

Age: the company must be less than 15 years old at the date of warrant issuance (raised from 7 years by LFI 2022).

Ownership: the company must be at least 25% owned by natural persons or by companies themselves owned by natural persons who do not control the issuing entity.

Listed status: the company must be unlisted, or listed on a regulated market with a market capitalisation below EUR 150 million (to be confirmed against the version of CGI Art. 163 bis G applicable at the date of issuance).

If any of these conditions ceases to be met after warrants have been issued, the BSPCE regime is preserved for warrants already issued but no new warrants can be issued under the regime.

The statute limits BSPCE to the following categories:

• Employees of the company with an active employment contract at the date of allocation
• Compensated executive officers: president, CEO (directeur general), deputy CEO (directeur general delegue) in a SAS or SA, managing partner in an SCA
• Compensated members of the board of directors or supervisory board

Cannot receive BSPCE: independent contractors, freelancers invoicing on a self-employed basis, and non-executive directors who receive no compensation for their mandate.

A recurring issue in practice: a co-founder who moves from an employment contract to an uncompensated presidency during a cash-tight period may lose eligibility. Eligibility is assessed at the date of each individual warrant allocation.

The exercise price is set by the competent company body and must reflect the fair value of the share at the date of issuance. In practice, French startups apply a discount of 20 to 30% relative to the valuation used in the most recent funding round, to reflect illiquidity and residual risk.

This discount must be supported by documented methodology: a valuation report, comparable transactions analysis, simplified DCF, or a certified appraiser's report. Without documentation, the tax authority (DGFiP) may argue that the exercise price is understated and reclassify part or all of the gain as salary income subject to the progressive income tax rate and social security contributions.

Vesting defines the schedule under which BSPCE rights vest progressively. The French market standard in 2026 is:

• Total duration: 4 years
• Cliff: 12 months (no rights vest before the cliff)
• Post-cliff vesting: monthly or quarterly (25% vested at the cliff, then 1/36th per month for 3 years)

The BSPCE plan must specify what happens in the event of departure (good leaver / bad leaver), dismissal, death, or permanent disability. These clauses are negotiated in the shareholders' agreement and are not standardised by law.

BSPCE taxation applies at the time of sale of shares acquired by exercising the warrants — not at allocation, not at exercise. The taxable gain equals: sale price minus exercise price.

At a 45% top marginal income tax rate, a beneficiary in a sub-3-year company could face a combined rate exceeding 62%. This is why BSPCE plans are almost universally structured for exits occurring after the company's 3rd anniversary.

For the beneficiary, the sale gain from BSPCE is not treated as salary. It is subject only to social levies on investment income at 17.2% — not to employee social security contributions covering health, pension, or unemployment insurance.

For the issuing company, allocating BSPCE creates no employer social charges — neither at allocation, exercise, nor sale. This stands in sharp contrast to Free Share awards (AGA), which carry a 20% employer contribution assessed on the value of shares at vesting.

Issuing BSPCE has no income statement impact for the company. A capital entry is recorded only when warrants are actually exercised. Prior to exercise, disclosure in the notes to the accounts is required (number of warrants allocated, exercise price, vesting schedule).

This P&L neutrality is a meaningful advantage for startups that do not wish to dilute their EBITDA figures when raising capital or preparing for an exit.

Our view: for an eligible SAS less than 15 years old, BSPCE remain the first choice in the vast majority of cases. AGA (free shares) are useful for senior hires who prefer an immediate gain at vesting without paying an exercise price upfront. BSA warrants are typically used for advisers, non-employee board members, or co-founder holding companies.

A well-structured BSPCE plan requires a managed dilution reserve. French market practice in 2026 sets the total equity incentive pool at 10 to 15% of post-money capital for growth-stage startups. The BSPCE-specific reserve typically represents 5 to 10% of capital.

The decision process requires an extraordinary general meeting (AGE) to authorise the plan, followed by allocation of individual warrants by the president or board under delegated authority. Each allocation must be documented in a signed individual allocation certificate.

Situation: a SaaS company incorporated as a SAS in 2020, 30 employees, EUR 12 million valuation at Series A in 2024, wishing to implement a BSPCE plan for 8 key engineers.

Eligibility check: SAS incorporated 2020, less than 15 years old in 2026 — satisfied. Unlisted — satisfied. Majority-owned by founding natural persons — satisfied.

Plan structure:

• Pool allocated: 5% of post-money capital
• Per-engineer allocation: 30,000 to 100,000 warrants depending on seniority
• Exercise price: EUR 0.90 (EUR 12M valuation at 25% discount from EUR 1.20 per share, supported by internal valuation report)
• Vesting: 4 years, 12-month cliff, monthly acceleration thereafter

Sale scenario (exit 2029, valuation EUR 60 million):

• Sale price per share: EUR 6.00
• Gain per warrant exercised: EUR 6.00 - EUR 0.90 = EUR 5.10
• For 50,000 warrants: gross gain = EUR 255,000
• Company > 3 years in 2029 — PFU 30% applies
• Tax: EUR 255,000 x 30% = EUR 76,500
• Net received: EUR 178,500

This scenario is illustrative. It assumes an effective liquidity event and does not account for ratchet clauses, anti-dilution provisions, or changes in applicable tax rates.

Understated exercise price: the DGFiP benchmarks the exercise price against recent funding round prices, comparable transactions, and any received acquisition offers. An exercise price materially below fair value may be reclassified as salary income.

Age condition breach: a company founded in 2010 that issues BSPCE in 2026 (16 years old) no longer meets the age condition. The issuance is void for BSPCE purposes.

Missing vesting documentation: without a contractually documented vesting schedule, the beneficiary could technically exercise immediately. In the event of departure, the absence of good/bad leaver clauses makes the plan operationally unmanageable.

Ineligible beneficiary: a consultant invoicing on a self-employed basis cannot receive BSPCE. The gain would be reclassified as non-commercial income (BNC), subject to the progressive income tax scale and self-employed social contributions.

Post-allocation loss of eligibility: if the company exceeds 15 years of age or converts to a SARL, existing warrants retain their regime in principle, but no new warrants can be issued under BSPCE.

• Verify company eligibility (legal form, age, ownership, listed status)
• Verify each beneficiary's eligibility (active employment contract or compensated mandate)
• Obtain and document a valuation at the date of allocation
• Set the exercise price with a justified and documented discount
• Obtain AGE authorisation for the plan
• Draft individual allocation certificates (vesting, good/bad leaver clauses)
• Register warrants in the company's securities movement register
• Disclose the plan in the notes to the annual accounts
• Anticipate the liquidity event (exit, secondary, share buyback clause)
• Confirm the company's 3-year age condition for the planned sale date

BSPCE remain the most efficient equity incentive tool for an eligible French startup in 2026. The combination of zero employer social charges and a 30% flat tax cap for beneficiaries has no equivalent among French equity instruments.

That said, implementation is more technical than it appears. The initial valuation, the drafting of allocation deeds, and ongoing monitoring of eligibility conditions are critical checkpoints. A poorly documented plan can be fully reclassified, turning a retention tool into a tax and social security adjustment that can amount to tens of thousands of euros per beneficiary.

Our recommendation: bring in your accountant and tax counsel at the design stage, before the first allocation. An eligibility and structuring review of 2 to 3 hours at the outset avoids reclassification risks that are far more costly to resolve after the fact.

This article provides general information only. It does not replace a review of your specific situation, articles of association, shareholders' agreement, and applicable tax rules at the date of allocation. Consult a chartered accountant or tax lawyer before making any decision.

Sources: CGI Art. 163 bis G and 200 A (Legifrance), BOFiP BOI-RSA-ES-20-20, URSSAF, LFI 2022, impots.gouv.fr.